KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Takeda Pharmaceutical (TAK) Assets (2018 - 2026)

Takeda Pharmaceutical has reported Assets over the past 9 years, most recently at $98.5 billion for Q1 2026.

  • For Q1 2026, Assets rose 5.51% year-over-year to $98.5 billion; the TTM value through Mar 2026 reached $98.5 billion, up 5.51%, while the annual FY2026 figure was $102.7 billion, 9.75% up from the prior year.
  • Assets was $98.5 billion for Q1 2026 at Takeda Pharmaceutical, up from $93.4 billion in the prior quarter.
  • Across five years, Assets topped out at $113.4 billion in Q1 2022 and bottomed at $93.4 billion in Q1 2025.
  • The 5-year median for Assets is $102.0 billion (2024), against an average of $102.6 billion.
  • Year-over-year, Assets fell 8.4% in 2025 and then rose 5.51% in 2026.
  • Over 5 years, Assets stood at $113.4 billion in 2022, then decreased by 6.94% to $105.5 billion in 2023, then decreased by 3.38% to $102.0 billion in 2024, then decreased by 8.4% to $93.4 billion in 2025, then grew by 5.51% to $98.5 billion in 2026.
  • The last three reported values for Assets were $98.5 billion (Q1 2026), $93.4 billion (Q1 2025), and $102.0 billion (Q1 2024) per Business Quant data.